Cem Mat M, Yazici H, Ozbakir F, Tüzün Y
Department of Dermatology, Cerrahpaşa Medical Faculty, University of Istanbul, Turkey.
Int J Dermatol. 1988 May;27(4):246-7. doi: 10.1111/j.1365-4362.1988.tb03218.x.
Among 50 patients with lepromatous leprosy and borderline lepromatous leprosy in Turkey, the prevalence of HLA-DR2 was 25/50 (50%). The prevalence of the same alleles among 50 healthy controls was 13/50 (26%).
在土耳其的50例瘤型麻风病和界线类偏瘤型麻风病患者中,HLA - DR2的患病率为25/50(50%)。在50名健康对照者中,相同等位基因的患病率为13/50(26%)。